Tomoyuki Katsuno

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans

Kahori Washio, Yoshiki Kusunoki, Takayo Murase et al. · Metabolism · 2017 · 75 citations

Medicine, Biochemistry, Endocrinology +16

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay

Toshihiro Matsuo, Jun‐ichiro Miyagawa, Yoshiki Kusunoki et al. · Journal of Diabetes Investigation · 2015 · 50 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects

Aya Maeda, Jun‐ichiro Miyagawa, Masayuki Miuchi et al. · Journal of Diabetes Investigation · 2013 · 45 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +14